AUTHOR=Kurihara Chieko , Baroutsou Varvara , Becker Sander , Brun Johan , Franke-Bray Brigitte , Carlesi Roberto , Chan Anthony , Collia Luis Francisco , Kleist Peter , Laranjeira Luís Filipe , Matsuyama Kotone , Naseem Shehla , Schenk Johanna , Silva Honorio , Kerpel-Fronius Sandor , on behalf of Working Group on Ethics of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine TITLE=Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics JOURNAL=Frontiers in Pharmacology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.579714 DOI=10.3389/fphar.2020.579714 ISSN=1663-9812 ABSTRACT=

Expansion of data-driven research in the 21st century has posed challenges in the evolution of the international agreed framework of research ethics. The World Medical Association (WMA)’s Declaration of Helsinki (DoH) has provided ethical principles for medical research involving humans since 1964, with the last update in 2013. To complement the DoH, WMA issued the Declaration of Taipei (DoT) in 2016 to provide additional principles for health databases and biobanks. However, the ethical principles for secondary use of data or material obtained in research remain unclear. With such a perspective, the Working Group on Ethics (WGE) of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) suggests a closer scientific linkage in the DoH to the DoT focusing specifically on areas that will facilitate data-driven research, and to further strengthen the protection of research participants.